Bank of America’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History
Bought
Maintained
Sold
Other funds holding LABU
TRCT
GS
TSS
MIG
CBU
AF
EFG
Bank of America's LABU Position: Q2 2026 in Review
Bank of America reduced its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 34% in Q2 2026, selling an estimated $160K and leaving 1,639 shares worth $479K. The position accounts for ﹤0.01% of the portfolio, ranked #4991.
Bank of America first reported a position in LABU in Q3 2016 and has held it in 20 quarters since. The position peaked at $6.76M in Q2 2024. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.
- Bank of America held 1,639 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $479K as of Q2 2026.
- Bank of America sold 837 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2026, an estimated $160K.
- Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #4991 holding.
- Bank of America first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2016 and has held it in 20 quarters since.
- Bank of America's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $6.76M in Q2 2024.
- 36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.
Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.